| Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 KL Ong, LK Stafford, SA McLaughlin, EJ Boyko, SE Vollset, AE Smith, ... The Lancet 402 (10397), 203-234, 2023 | 1961 | 2023 |
| Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … AJ Ferrari, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, ... The Lancet 403 (10440), 2133-2161, 2024 | 552 | 2024 |
| Global burden of cardiovascular diseases and risks, 1990-2022 GA Mensah, V Fuster, CJL Murray, GA Roth, ... Journal of the American College of Cardiology 82 (25), 2350-2473, 2023 | 528 | 2023 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 517 | 2024 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 319 | 2024 |
| Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 SE Vollset, HS Ababneh, YH Abate, C Abbafati, R Abbasgholizadeh, ... The Lancet 403 (10440), 2204-2256, 2024 | 225 | 2024 |
| Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 VL Feigin, MD Abate, YH Abate, S Abd ElHafeez, F Abd-Allah, ... The Lancet Neurology 23 (10), 973-1003, 2024 | 100 | 2024 |
| Global burden of peripheral artery disease and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 MS Kim, J Hwang, DK Yon, SW Lee, SY Jung, S Park, CO Johnson, ... The Lancet Global Health 11 (10), e1553-e1565, 2023 | 72 | 2023 |
| Effects of angiotensin receptor blockers (ARBs) on in-hospital outcomes of patients with hypertension and confirmed or clinically suspected COVID-19 A Soleimani, S Kazemian, S Karbalai Saleh, A Aminorroaya, Z Shajari, ... American Journal of Hypertension 33 (12), 1102-1111, 2020 | 60 | 2020 |
| Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019 D Wu, Y Jin, Y Xing, MD Abate, M Abbasian, M Abbasi-Kangevari, ... EClinicalMedicine 64, 2023 | 53 | 2023 |
| Risk indicators associated with in-hospital mortality and severity in patients with diabetes mellitus and confirmed or clinically suspected COVID-19 M Pazoki, M Keykhaei, S Kafan, M Montazeri, M Mirabdolhagh Hazaveh, ... Journal of Diabetes & Metabolic Disorders 20 (1), 59-69, 2021 | 33 | 2021 |
| Efficacy and safety of same‐day discharge after atrial fibrillation ablation: A systematic review and meta‐analysis S Rashedi, H Tavolinejad, S Kazemian, M Mardani, M Masoudi, ... Clinical cardiology 45 (2), 162-172, 2022 | 32 | 2022 |
| The risk factors and clinical outcomes associated with acute kidney injury in patients with COVID-19: data from a large cohort in Iran H Rahimzadeh, S Kazemian, M Rahbar, H Farrokhpour, M Montazeri, ... Kidney and Blood Pressure Research 46 (5), 620-628, 2021 | 30 | 2021 |
| National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050 M Ng, X Dai, RM Cogen, M Abdelmasseh, A Abdollahi, A Abdullahi, ... The lancet 404 (10469), 2278-2298, 2024 | 29 | 2024 |
| Methodological insights into ChatGPT’s screening performance in systematic reviews M Issaiy, H Ghanaati, S Kolahi, M Shakiba, AH Jalali, D Zarei, ... BMC medical research methodology 24 (1), 78, 2024 | 24 | 2024 |
| Toll-like receptor 7 regulates cardiovascular diseases M Shafeghat, S Kazemian, A Aminorroaya, Z Aryan, N Rezaei International Immunopharmacology 113, 109390, 2022 | 24 | 2022 |
| Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease … D Bryazka, MB Reitsma, YH Abate, AHA Abd Al Magied, A Abdelkader, ... The lancet Public health 9 (10), e729-e744, 2024 | 19 | 2024 |
| COVID-19 in Iran: clinical presentations and outcomes in three different surges of COVID-19 infection A Hadadi, M Pirzadeh, S Kazemian, H Ashraf, M Ebrahimi, ... Virology Journal 19, 123, 2022 | 13 | 2022 |
| Takotsubo syndrome and COVID‐19: A systematic review H Ghasemi, S Kazemian, SA Nejadghaderi, M Shafie Health Science Reports 6 (1), e972, 2022 | 12 | 2022 |
| Administration of breast milk cell fractions to neonates with birthweight equal to or less than 1800 g: a randomized controlled trial M Fallahi, SM Shafiei, NT Taleghani, MK Shariati, S Noripour, ... International Breastfeeding Journal 16 (1), 1-9, 2021 | 12 | 2021 |
Haleh AshrafAssociate Professor of Cardiology, fellowship of Advanced heart failure and tEmail yang diverifikasi di sina.tums.ac.ir